Profil
Stephen Goodall is the founder of Firebrick Pharma Ltd., which is founded in 2012, where he holds the title of Chief Operating Officer & Director.
He was also a Director-Pharmaceutical Development at Vapotronics, Inc. from 1999 to 2001 and the Chief Operating Officer at Viralytics Pty Ltd.
from 2008 to 2011.
Aktive Positionen von Stephen Goodall
| Unternehmen | Position | Beginn |
|---|---|---|
| FIREBRICK PHARMA LIMITED | Gründer | 12.04.2012 |
Ehemalige bekannte Positionen von Stephen Goodall
| Unternehmen | Position | Ende |
|---|---|---|
| VIRALYTICS LTD. | Geschäftsführer | 31.08.2011 |
Vapotronics, Inc.
 Vapotronics, Inc. Medical SpecialtiesHealth Technology Vapotronics, Inc. develops inhalation drug products. The company is headquartered in South Brisbane, Australia. | Corporate Officer/Principal | 01.06.2001 |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Börsennotierte Unternehmen | 1 |
|---|---|
| FIREBRICK PHARMA LIMITED | Health Technology |
| Private Unternehmen | 2 |
|---|---|
Viralytics Pty Ltd.
 Viralytics Pty Ltd. BiotechnologyHealth Technology Viralytics Pty Ltd. engages in the development and commercialization of oncolytic immunotherapies that harness the power of certain viruses to infect and kill cancer cells. Its product, CAVATAK, is a genetically unmodified proprietary formulation of the common cold Coxsackievirus Type A21. The company was founded in 1984 and is headquartered in Sydney, Australia. | Health Technology |
Vapotronics, Inc.
Vapotronics, Inc. Medical SpecialtiesHealth Technology Vapotronics, Inc. develops inhalation drug products. The company is headquartered in South Brisbane, Australia. | Health Technology |
